- 2025 - 2029 がん染色体外環状DNAを標的とした新規リキッドバイオプシー検査の開発
- 2023 - 2026 核小体内におけるRNA polymerase IIによるribosomal RNAの転写と癌化機構の解明
- 2021 - 2025 Widely-applicable improvement of infectious disease testing (including COVID-19) by selective analysis of single-stranded DNA/ RNA
- 2021 - 2025 Widely-applicable improvement of infectious disease testing (including COVID-19) by selective analysis of single-stranded DNA/ RNA
- 2022 - 2024 長鎖DNA解析を基盤とする臨床検査群を可能とする本邦発のプラットフォームの開発
- 2021 - 2024 マルチオミクスを用いた新規歯周疾患マーカーの開発
- 2020 - 2023 がん細胞のリボソーム構成タンパク質の発現解析と転写後調節への関与
- 2019 - 2023 The establishment of the trust among stakeholders and patients for sharing the medical and genomic records by centralized and decentralized storage methods
- 2018 - 2023 ユビキトーム解析による歯周疾患のバイオマーカー開発
- 2018 - 2022 Development of a new meaningful clinical bacteriological test based on metagenomic and DNA methylation analysis
- 2017 - 2021 Establishment of detection methods of early cancers with chronic inflammation by non-viral mechanism
- 2018 - 2020 臨床検査応用を目指したLC-MS/MS定量測定法の開発と基盤技術の構築
- 2015 - 2018 Development of the quantitative measurement methods by LC-MS/MS for clinical laboratory applications.
- 2015 - 2018 Development of immunocomplex pretreatment method for mass spectrometry (MS, Immuno-MS) which is applicable to clinical testing
- 2015 - 2017 Development of LC-MS/MS-based accurate quantification methods for assessing serum vitamin D metabolites
- 2013 - 2015 Multidisciplinary modificomics to search for novel and early markers to detect hepatobiliary cancers
- 2012 - 2015 Clinical marker hunting with informatics and mass spectrometry
- 2009 - 2011 Identification and quantitation of low abundant tumor marker candidates in plasma derived from cancer tissue using recent proteomic technologies
- 2009 - 2011 An Exploratory Approach for Non-Alcoholic Steato Hepatitis Biomarker Identification with Proteome and Transcriptome Analysis.
Show all